GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024
Project NextGen (PNG) Award In June 2024 ... enrollment of the experimental arm utilizing GEO-CM04S1, but that the mRNA control arm of the study should be halted as it failed to meet the ...
The LV138with_HE.png file, stored in the HE folder ... indicate a trend toward diminished overall survival with increased transcription of the corresponding mRNA. This observation supports the ...
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...
But scientists at Moderna are in the late stages of testing what could be the first such shot, using mRNA technology against the virus. Here’s what to know about norovirus and where things stand ...
6don MSN
RFK Jr.'s dismissal of vaccine science during Senate hearings raises concerns about his fitness for HHS secretary role.
Wall Street is off to a volatile start in 2025, with investors stepping on the sell pedal after last week's jobs data, followed by a sharp about-face in sentiment following Wednesday's consumer ...
Shares in CureVac have plummeted after a German court ruled that a patent it holds on mRNA-based COVID-19 vaccines was invalid. The validity of the patent is at the heart of patent litigation ...
The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.
Market is currently closed. Voting is open during market hours.
A genome-wide analysis of the RNA in the brains of individuals with autism reveals consistent patterns of abnormal gene expression and implicates several molecular pathways in the pathology of autism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results